Varian Shareholders OK Agilent Acquisition | GenomeWeb

NEW YORK (GenomeWeb News) – Varian today said that its shareholders have approved the firm's merger agreement with Agilent Technologies.

The deal, under which Agilent will acquire Varian for $52 per share in cash — for a total transaction value of around $1.5 billion — was announced in late July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.